Table 4 Differences between active substances use among groups for the main drug classes

ANTIBACTERIALS FOR SYSTEMIC USE

100,0

91.2

.07

48

14

Ampicillin^a

97.1

87.5

.07

7

5

.16

Amikacin^a

97.1

35.2

<.0001

7

4

.33

Piperacillin and enzyme inhibitor^a

47.1

12.1

<.0001

13

11

.03

Metronidazole

39.7

7.7

<.0001

13

9

.10

Vancomycin^a

35.3

14.3

<.0001

13

13

.01

Clarithromycin

29.4

5.5

<.0001

15

13

.02

Erythromycin ethylsuccinate

19.1

2.2

<.0001

15

8

.25

ANTIMYCOTICS FOR SYSTEMIC USE

92.6

49.5

<.0001

36

18

Fluconazole

92.6

49.5

<.0001

32

18

.78

Amphotericin B^a

13.2

1.1

.03

20

1

.01

RESPIRATORY SYSTEM PRODUCTS

55.9

39.6

.02

7

3

Lung surfactant - natural phospholipidis

45.6

37.4

.69

3

1

.85

Doxapram

17.6

6.6

.21

15

14

.32

Caffeine

95.6

75.8

.02

45

27

n.a.

DIURETICS

83.8

31.9

<.0001

65

26

Furosemide^a

72.1

25.3

.77

12

11

.08

Hydrochlorothiazide

50,0

8.8

.07

46

26

.31

Spironolactone

50,0

8.8

.07

46

26

.31

CARDIAC THERAPY

55.9

28.6

<.0001

23

9

Dopamine

44.1

12.1

.10

12

7

.52

Dobutamine

36.8

5.5

.02

7

11

.02

Ibuprofen^a

32.4

12.1

.43

2

2

.37